Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction
NCT01244698 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2014-05-13
Summary
Antibiotics are used routinely in postoperative tissue expander based breast reconstruction (TE) and autologous flap (AF) breast reconstruction procedures. Closed suction drains are also used routinely in immediate breast reconstruction to prevent fluid accumulation and seroma formation at the surgical sites. Antibiotics are most often prescribed as a precaution since drains can be a source for infection by creating open channels to outside contaminants. Plastic surgery patients without closed suction drainage devices are usually not placed on prolonged postoperative antibiotics. Current preoperative surgical antibiotic prophylaxis is recommended for up to 24 hours only. These recommendations do not take into account the increased risk of indwelling closed suction drains. A recent survey of plastic surgeons, conducted by SBUMC investigators, (IRB# 129415) found that Plastic Surgeons are divided as to extended outpatient administration following TE breast reconstruction.
The study plans to prospectively enroll patients who will undergo immediate breast reconstruction with TE or AF based breast reconstruction. Using the above data and the current protocol, the investigators will investigate the optimal antibiotic discontinuation period for these patients. The investigators hypothesize that the use of 24-hour perioperative antibiotics in TE or AF based immediate breast reconstruction with closed suction drainage, does not result in an increased infection rate compared to prolonged postoperative antibiotic administration.
Conditions
- Bacterial Infection
- Anti-infective Agents
- Breast Implantation
Interventions
- DRUG
-
Cefadroxil discontinued early
All patients will receive 24 hours of IV Cefazolin (1g IV every 8 hr), as is universal practice for clean breast surgery. The interventional group will then discontinue antibiotics. Clindamycin IV 600mg every 6 hours for 24 hours will be used in penicillin allergic patients.
- DRUG
-
Cefadroxil until drain removal
All patients will receive 24 hours of IV Cefazolin, as is universal practice for clean breast surgery. The control group will receive oral outpatient Cefadroxil (500mg 2 times a day) until the final drain is removed. This is the normal postoperative regimen. In case of significant penicillin allergy (defined as a history of urticaria or anaphylaxis associated with penicillin) patients will receive Clindamycin 600mg IV every 6 hours for 24 hours followed by clindamycin 300mg IV every 6 hours.
Sponsors & Collaborators
-
The Plastic Surgery Foundation
collaborator OTHER - lead OTHER
Principal Investigators
-
Duc T Bui, MD · Stony Brook University Medical Center
-
Brett T Phillips, MD · Stony Brook University Medical Center
-
Duc T Bui, MD · Stony Brook University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
NCT06744907 ·Status: RECRUITING ·Phase: PHASE4
-
Silicone Taping for the Improvement of Abdominal Donor Site Scars
NCT04506255 ·Status: RECRUITING ·Phase: NA
-
The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe
NCT01389232 ·Status: COMPLETED ·Phase: NA
-
Wound Dressings For Split-Thickness Skin Graft Donor Sites in Patients Undergoing Surgery
NCT01680367 ·Status: COMPLETED ·Phase: NA
-
Do Topical Antibiotics Improve Skin Graft Results?
NCT07286851 ·Status: COMPLETED
-
Efficacy and Safety of High Absorption Pad in Split-thickness Skin Graft Donor Site Wound
NCT04299126 ·Status: UNKNOWN ·Phase: NA
-
Diced Cartilage in Breast Reconstruction
NCT06504173 ·Status: COMPLETED
-
Antibiotic-coated Braided Suture Study
NCT07322289 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
NCT03002506 ·Status: TERMINATED ·Phase: PHASE4
-
Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)
NCT04292054 ·Status: RECRUITING ·Phase: PHASE3
-
Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh
NCT01769144 ·Status: UNKNOWN ·Phase: NA
-
NovoX®Cup as Primary Dressing After Breast Reduction
NCT06420323 ·Status: RECRUITING
-
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
NCT04169438 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars
NCT01789346 ·Status: COMPLETED ·Phase: NA
-
DMSO for Prevention of Capsular Contraction in Alloplastic Breast Reconstruction
NCT02206477 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery
NCT01053897 ·Status: COMPLETED ·Phase: PHASE2
-
PICO Breast Reduction Clinical Study Looking at Incision Healing Complications
NCT01640366 ·Status: COMPLETED ·Phase: NA
-
Study of Prineo (Dermabond Protape) Versus Sutures in Breast Procedures
NCT00558246 ·Status: COMPLETED ·Phase: PHASE4
-
Autologous Point-of-Care Adipose Therapy: Recent Injury
NCT06857448 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
NCT05945329 ·Status: RECRUITING ·Phase: NA
-
Tissue Expander Breast Reconstruction Study on Breast Volume and Shape Change
NCT01222390 ·Status: COMPLETED ·Phase: NA
-
A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery
NCT04331080 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage
NCT00565552 ·Status: UNKNOWN ·Phase: NA
-
Recipient Site Pre-conditioning in Fat Grafting
NCT03393598 ·Status: COMPLETED ·Phase: NA
-
Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks
NCT00675922 ·Status: TERMINATED ·Phase: PHASE2/PHASE3